Cambridge Investment Research Advisors’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Hold |
31,445
| – | – | ﹤0.01% | 3507 |
|
|
2025
Q1 | $136K | Sell |
31,445
-190
| -0.6% | -$822 | ﹤0.01% | 3297 |
|
|
2024
Q4 | $60K | Hold |
31,635
| – | – | ﹤0.01% | 3364 |
|
|
2024
Q3 | $124K | Sell |
31,635
-4,850
| -13% | -$19K | ﹤0.01% | 3234 |
|
|
2024
Q2 | $239K | Buy |
36,485
+4,548
| +14% | +$29.8K | ﹤0.01% | 2885 |
|
|
2024
Q1 | $195K | Buy |
31,937
+134
| +0.4% | +$818 | ﹤0.01% | 3030 |
|
|
2023
Q4 | $399K | Buy |
31,803
+101
| +0.3% | +$1.27K | ﹤0.01% | 2375 |
|
|
2023
Q3 | $563K | Sell |
31,702
-15
| -0% | -$266 | ﹤0.01% | 1991 |
|
|
2023
Q2 | $550K | Buy |
31,717
+1,152
| +4% | +$20K | ﹤0.01% | 2055 |
|
|
2023
Q1 | $726K | Sell |
30,565
-1,207
| -4% | -$28.7K | ﹤0.01% | 1795 |
|
|
2022
Q4 | $513K | Buy |
31,772
+190
| +0.6% | +$3.07K | ﹤0.01% | 1992 |
|
|
2022
Q3 | $740K | Sell |
31,582
-4,896
| -13% | -$115K | ﹤0.01% | 1680 |
|
|
2022
Q2 | $796K | Buy |
36,478
+561
| +2% | +$12.2K | ﹤0.01% | 1633 |
|
|
2022
Q1 | $910K | Hold |
35,917
| – | – | ﹤0.01% | 1641 |
|
|
2021
Q4 | $970K | Buy |
+35,917
| New | +$970K | ﹤0.01% | 1600 |
|